Table 1

Detailed patient information

CaseIOP control*Type of glaucomaSexAge (years)Preop IOP (mmHg)Postop IOP (mmHg)Duration from surgery to thermography (months)Base of the conjunctival flapIBAGS gradeTDB (°C)
HEVS
1GoodPOAGF83371412Limbal21100.55
2GoodPOAGF8330156Limbal22110.30
3GoodPOAGF79171112Fornix11100.55
4GoodPOAGF77241316Fornix12300.35
5GoodPOAGF74171349Limbal23100.45
6GoodPOAGF74351214Fornix22200.45
7GoodPOAGF7424914Fornix22200.25
8GoodPOAGF67331112Fornix22010.70
9GoodPOAGM83201320Fornix22000.60
10GoodPOAGM62311326Limbal33100.45
11GoodPOAGM5516137Limbal22100.70
12GoodPOAGM5516146Limbal21110.40
13GoodPEGF7418136Limbal00200.85
14GoodPEGF7418136Limbal00300.95
15GoodPEGF70241013Limbal22300.20
16GoodPEGM8520737Limbal11200.45
17GoodPEGM8425126Limbal00300.40
18GoodPEGM7035854Limbal13000.45
19GoodPEGM6728136Limbal00300.95
20GoodSG-nF7238843Fornix22100.70
21GoodSG-nF66471014Fornix32100.55
22GoodSG-uF65241629Limbal32100.70
23GoodSG-nM7028166Limbal33010.50
24PoorPOAGM821916†28Fornix12300.25
25PoorPOAGM762814†12Limbal12010.30
26PoorPOAGM761817‡40Limbal11000.55
27PoorPOAGM741816‡43Limbal11000.45
28PoorPOAGM692816†24LImbal00300.20
29PoorPOAGM483514†55Limbal12200.05
30PoorPEGM813015‡33Fornix0020−0.05
31PoorPACGF692217‡27Fornix00200.05
32PoorPOAGF772221‡60Limbal10300.15
33PoorPOAGM722523‡12Limbal11200.10
34PoorPOAGM704223‡11Fornix11300.00
35PoorPOAGM661924‡43Limbal23000.15
36PoorPEGM792823†6Limbal32300.40
37PoorPEGM752621†12Fornix11110.05
38PoorSG-iF484624‡19Limbal33100.20
39PoorSG-nF404226‡6Limbal33100.50
  • E, extent; H, height; IBAGS, Indiana Bleb Appearance Grading Scale; PACG, primary angle-closure glaucoma; PEG, pseudoexfoliation glaucoma; POAG, primary open-angle glaucoma; S, Seidel test; SG, secondary glaucoma caused by neovascularisation of the angle (-n), uveitis (-u), or the iridocorneal endothelial syndrome (-i); TDB, temperature decrease in the filtering bleb: V, vascularity.

  • *Good: IOP <21 mmHg without antiglaucoma medications; poor: filtering blebs with antiglaucoma medications for elevated IOP.

  • †With two topical medications; ‡with three topical medications.